T re a tme nt o f Mo o d Diso rde rs in Midlife Disc lo sure s I - - PDF document

t re a tme nt o f mo o d diso rde rs in midlife
SMART_READER_LITE
LIVE PREVIEW

T re a tme nt o f Mo o d Diso rde rs in Midlife Disc lo sure s I - - PDF document

10/5/2017 T re a tme nt o f Mo o d Diso rde rs in Midlife Disc lo sure s I HAVE NO DISCL OSURE S Wo me n K AY ROU SSOS-ROSS, MD U NI VE RSI T Y OF FL ORI DA DE PART ME NT S OF OBGYN AND PSYCHI AT RY T o da y s F o c


slide-1
SLIDE 1

10/5/2017 1

T re a tme nt o f Mo o d Diso rde rs in Midlife Wo me n

K AY ROU SSOS-ROSS, MD U NI VE RSI T Y OF FL ORI DA DE PART ME NT S OF OBGYN AND PSYCHI AT RY

Disc lo sure s

I HAVE NO DISCL OSURE S

Ob je c tive s

  • UNDE

RST AND INCI DE NCE OF MOOD DISORDE RS IN MIDL I F E WOME N

  • DISCUSS PAT

HOPHYSIOL OGY OF MOOD DISORDE RS IN MIDL I F E WOME N

  • IDE

NT I F Y APPROPRIAT E T RE AT ME NT OPT IONS OF MOOD DISORDE RS IN MIDL I F E WOME N

T

  • da y’ s F
  • c us: Midlife Wo me n

Midlife wo me n=Me no pa usa l tra nsitio n (MT )= Pe rime no pa use =Clima c te ric

I nc lude s time fra me b e twe e n full re pro duc tive func tio n a nd me no pa use (De ll e t a l. Me no pa use a nd Mo o d. 2000)

 T

ime fra me typic ally 4-8 ye a rs in le ng th

 T

ypic a lly o c c urs in 45-55 ye a r o ld wo me n

 Ave ra g e a g e 47 ye a rs o ld

slide-2
SLIDE 2

10/5/2017 2

E xe c utive Summa ry o f the Sta g e s o f Re pro duc tive Ag ing Wo rksho p + 10: Addre ssing the Unfinishe d Ag e nda o f Sta g ing Re pro duc tive Ag ing . Ha rlo w e t a l. J Clin E ndo c rino l Me ta b . 2012

E pide mio lo g y

Mo o d diso rde rs a re twic e a s c o mmo n in wo me n a s in me n

 T

his distinc tio n o c c urs in a do le sc e nc e a nd e q ua lize s a fte r me no pa use  15-50% o f wo me n e xpe rie nc e de pre ssive sympto ms during the me no pa usa l tra nsitio n (MT ) (T

  • ffo l e t a l. Me no pa use . 2015)

 15-30% me e t c rite ria fo r de pre ssive diso rde rs  T

he re is a 2x inc re a se d risk o f a first e piso de o f de pre ssio n fo r wo me n in MT

 SWAN study sho we d wo me n 2-4x mo re like ly to e xpe rie nc e MDD if the y we re

pe rime no pa usa lo r e a rly po stme no pa usa l (Bro mb e rg e re t a l. Psyc ho l Me d. 2011)

 Se a ttle midlife Wo me n’ s He a lth Study fo und a do ub ling o f the ra te o f de pre ssive

sympto ms in la te MT (Wo o ds e t a l. Me no pa use . 2008)

Risk F a c to rs fo r Mo o d Diso rde rs in Midlife

Prio r de pre ssive e piso de *

 E

spe c ia lly if re la te d to prio r re pro duc tive e ve nt (So a re s. Me no pa use . 2014)  Sig nific a nt va so mo to r sympto ms  Psyc ho so c ia l stre sso rs

 F

ina nc ial stre ss

 Cha ng e s in wo rk-life  Divo rc e , Childre n le a ving fo r c o lle g e , Ca ring fo r e lde rly pa re nts 

He a lth re la te d issue s

Pa tho physio lo g y o f Mo o d Diso rde rs in Midlife

Do mino the o ry

 Va so mo to r sympto ms trig g e r de pre sse d mo o d due to disruptio n in sle e p a nd

func tio nal impairme nt (Go rdo n e t a l. Curr Psyc h Re p. 2014)

 Ho t flushe s pro vo ke sle e p d isturb a nc e whic h a ffe c ts mo o d

E mpty Ne st Syndro me

 Wo me n b e c o me mo re a wa re o f the ir lo ss o f fe rtility a nd the ir ma te rna l ro le  Psyc ho so c ia l stre sso rs: Cha ng e s in fa mily dyna mic , c ha ng e s in wo rk life ,

c ha ng e s in fina nc ial se c urity o c c ur a t the sa me time a s MT a nd ma y c a use de pre ssive sympto ms

slide-3
SLIDE 3

10/5/2017 3

Pa tho physio lo g y o f Mo o d Diso rde rs in Midlife

Ho rmo na l fluc tua tio n

 E

vide nc e o f wo rse ning o f mo o d diso rde rs during time s o f ho rmo na l fluc tua tio n

 Re la te d to me nse s (o nse t o f me nse s, pre me nstrua l d yspho ric d iso rd e r-PMDD)  Re la te d to pre g na nc y o r po stpa rtum  Re la te d to me no pa usa l tra nsitio n  Histo ry o f PMDD a nd / o r po stpa rtum d e pre ssio n a re risk fa c to rs fo r d e pre ssio n d uring me no pa usa l tra nsitio n (Wo o d s e t a l. Me no pa use . 2008, F re e ma n. Arc h Ge n Psyc h. 2004)  E

vide nc e tha t inc ide nc e o f de pre ssio n in po stme no pa usa l a g e d wo me n is simila r to tha t o f me n

 Altho ug h e stro g e n le ve ls a re lo w, the le ve ls o f e stro g e n a re sta b le a nd no t fluc tua ting

Pa tho physio lo g y o f Mo o d Diso rde rs in Midlife

Ab rup t c ha ng e s in ho rmo ne le ve ls ma y a lte r the e q uilib rium o f ne uro tra nsmitte rs fo und in the b ra in thus inc re a sing risk o f mo o d diso rde rs

 E

ST ROGE N

Ro le o f E stro g e n in T re a tme nt o f Mo o d Diso rde rs in Midlife Wo me n

Mo dula te s se ro to nin a nd no re pine phrine

I nc re a se s GABA a c tivity

De c re a se s a c tivity o f MAO (invo lve d in se ro to nin de g ra da tio n)

I nc re a se s trypto pha n hydro xyla se (invo lve d in se ro to nin synthe sis)

Se le c tive ly inc re a se s se ro to nin re c e pto r de nsity in b ra in

Pro mo te s NE a va ila b llity

I nvo lve d in inc re a sing NE hydro xyla tio n fro m do pa mine (So a re s. Me no pa use . 2014)

Dia g no sis o f Ma jo r De pre ssive Diso rde r

DSM V Dia g no stic Crite ria (5 sympto ms fo r 2 we e k pe rio d )

De pre sse d mo o d o r a nhe d o nia *

  • Cha ng e s in sleep

  • L
  • ss o f inter

est/ ple a sure

  • Guilt/ wo rthle ssne ss

  • F

a tig ue / lo ss o f ener gy

  • De c re a se d fo c us o r concentr

ation

– Cha ng e s in appetite o r we ig ht

– Cha ng e s in a c tivity (psychomotor )

– T ho ug hts o f d e a th/ suicide

slide-4
SLIDE 4

10/5/2017 4

T re a tme nt Optio ns fo r Wo me n in MT

 Antide pre ssa nts SNRI SSRI  E

stro g e n

Ora l T

ra nsde rma l

Psyc ho the ra py Co g nitive -Be ha vio ra l

T he ra py

 Co mple me nta ry

me dic ine

Ac upunc ture

T he ra py

Co g nitive -Be ha vio ra l T he ra py (CBT )

 CBT

  • ffe rs impro ve me nt in ho t flushe s a nd nig ht swe a ts b y c ha ng ing the

c o g nitive a ppra isa l o f sympto ms (No rto n e t a l. Me no pa use . 2014)

 T

e le pho ne g uide d se lf he lp CBT impro ve d sympto ms o f ho t flushe s a nd nig ht swe a ts (Ste fa no po ulo u e t a l. Ma turita s. 2014)

Co mple me nta ry Me dic ine

Ac up unc ture

 No c le a r e vide nc e o f impro ve me nt o f va so mo to r sympto ms o r mo o d in

pe rime no pa usa lwo me n (Cho e t a l. Me no pa use . 2009, Do din e t a l. Co c hra ne Da ta Ba se Syst Re v. 2013)

Antide pre ssa nts

Sid e E ffe c ts (15-20% o f pa tie nts)

GI sympto ms (na use a )

Se xua l dysfunc tio n (20%)

He a d a c he

Sle e p d isturb a nc e

Sho uld se e impro ve me nt in sympto ms within 1 mo nth

Antid e pre ssa nts

 SNRI  Dulo xe tine (20-60 mg )  Ve nla fa xine (37.5-225 mg )  SSRI  F

luo xe tine (10-40 mg )

 Se rtra line (50-150 mg )  Cita lo pra m (20-40 mg )  E

sc ita lo pra m (10-20 mg )

 Pa ro xe tine (20-50 mg )

slide-5
SLIDE 5

10/5/2017 5

Antide pre ssa nts: SNRI vs SSRI

In a po o le d a na lysis, SNRIs sho we d hig he r re missio n ra te s tha n SSRIs (E ntsua h e t a l. J Clin Psyc hia try 2001)

Go o d e vid e nc e o f impro ve me nt in sympto ms with c ita lo pra m, e sc ita lo pra m, pa ro xe tine , ve nla fa xine a s mo no the ra py

Go o d e vid e nc e fo r using c ita lo pra m a nd mirta za pine a s a d junc t to e stro g e n whe n e stro g e n a lo ne is insuffic ie nt in a id ing mo o d (Jo ffe e t a l. J Wo me ns He a lth Ge nd Ba se d Me d. 2001, So a re s e t a l. J Clin Psyc hia try. 2003)

If a wo ma n ha s ha d suc c e ss in the pa st with a c e rta in a ntid e pre ssa nt sho uld sta rt with tha t a ntid e pre ssa nt a s 1st line re g a rd le ss o f c la ss

If a wo ma n is ta king ta mo xife n sho uld use SNRI inste a d o f SSRI d ue to c o nc e rn a b o ut inte rfe re nc e with me ta b o lism o f ta mo xife n with SSRI (Stub b s e t a l. J Okla Sta te Me d Asso c . 2017)

CYP2D6 inhib ito rs- pa ro xe tine , fluo xe tine

Ro le o f E stro g e n in T re a tme nt o f Mo o d Diso rde rs in Midlife Wo me n

E stro g e n a s tre a tme nt

 Pe rime no pa usa lwo me n with MDD tre a te d with e stra dio l mo no the ra py ha ve

impro ve me nt in mo o d similar to tha t with a ntide pre ssa nts

 T

ra nsde rma l e stra dio l (50-100 mic ro g ra m/ da y) re sulte d in 60-75% o f sub je c ts no ting pa rtia l o r to ta l re missio n in de pre ssive e piso de s c o mpa re d to 20-30% o f sub je c ts re c e iving pla c e b o (So a re s e t a l. Arc h Ge n Psyc hia try. 2001, Sc hmidt e t a l. Am J Ob ste t Gyne c o l. 2000)

 Po stme no pa usa l wo me n do no t ha ve the sa me impro ve me nt in de pre ssive

sympto ms with e stra dio l mo no the ra py

 Da ta sho ws e stra dio l ma y b e use d a s a ug me nta tio n fo r wo me n with

ina de q ua te re spo nse to a ntide pre ssa nts a lo ne

 E

stro g e n tre a tme nt sho uld sho w impro ve me nt within the 1st mo nth o f use

Ro le o f Pro g e stins in T re a tme nt o f Mo o d Diso rde rs in Midlife Wo me n

Adding a pro g e stin to e stro g e n the ra py ma y a tte nua te the b e ne fic ia l e ffe c ts o f e stro g e n o n mo o d (So a re s. Me no pa use . 2014)

 I

nc re a se s c o nc e ntra tio n o f MAO c a using d e c re a se in se ro to nin c o nc e ntra tio n (Ste ine r e t a l. J Affe c tive Diso rde rs. 2003)

 Oppo site e ffe c t fro m e stro g e n

F

  • r wo me n with inta c t ute rus

 Cyc lic use o f pro g e ste ro ne ma y b e le ss ha rmful to mo o d in wo me n who

re spo nd we ll to e stro g e n (Co he n e t a l. Ame r J Me d 2005)

 L

e vo no rg e stre l I UD ma y b e a no the r o ptio n

T re a tme nt Stra te g ie s

Ho w to de c ide whic h tre a tme nt

 Mo o d sympto ms a nd va so mo to r sympto ms fre q ue ntly c o inc ide  Prima ry mo o d sympto ms- SNRI , SSRI  Prima ry va so mo to r sympto ms-E stro g e n

 Ora l vs T ra nsd e rma l fo rmula tio ns  If ute rus pre se nt must still use pro g e ste ro ne  Bo th sympto ms e q ua lly b o the rso me - c o nsid e r d ua l the ra py with a ntid e pre ssa nt a nd

e stro g e n

slide-6
SLIDE 6

10/5/2017 6

Othe r Co nside ra tio ns

Wo me n in me no pa use tra nsitio n ma y still o vula te

 Me no pa usa l do se s o f e stro g e n a nd pro g e ste ro ne ma y no t suppre ss o vula tio n  I rre g ula r b le e d ing ma y o c c ur  Co nside r le vo no rg e stre l I

UD plus e stro g e n

 Co nside r e stro g e n-pro g e stin fo rmula tio ns with suffic ie nt do se o f pro g e stin to

suppre ss o vula tio n

 E

E 5 mc g / NE T A 1mg

 E

2 1 mg / NE T A 0.5mg

Co nc lusio ns

Mo o d diso rde rs in midlife wo me n c a n b e de b ilita ting

T he re a re ma ny o ptio ns fo r tre a tme nt

 Ho rmo na l  Psyc ho tro pic  T

he ra pe utic

 Co mb inatio n o f a b o ve